Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)

Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)

Summary: Background: Little is known about how demographic, behavioural, and vaccine-related factors affect risk of post-vaccination SARS-CoV-2 infection. We aimed to identify risk factors for SARS-CoV-2 infection after primary and booster vaccinations. Methods: This prospective, population-based,...

Full description

Bibliographic Details
Main Authors: Giulia Vivaldi, David A. Jolliffe, Hayley Holt, Florence Tydeman, Mohammad Talaei, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Adrian R. Martineau
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:The Lancet Regional Health. Europe
Subjects:
SARS-CoV-2
Vaccination
Breakthrough infection
ChAdOx1
BNT162b2
mRNA-1273
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776222001971

Internet

http://www.sciencedirect.com/science/article/pii/S2666776222001971

Similar Items